Company Inogen, Inc.

Equities

INGN

US45780L1044

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
8.07 USD +1.32% Intraday chart for Inogen, Inc. +13.34% +46.99%

Business Summary

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.

Number of employees: 834

Sales per Business

USD in Million2022Weight2023Weight Delta
Oxygen Concentrators and Related Accessories
79.7 %
321 85.0 % 252 79.7 % -21.51%
Respiratory Products
20.3 %
57 15.0 % 64 20.3 % +12.98%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
71.7 %
276 73.2 % 226 71.7 % -18.05%
Non-United States
28.3 %
101 26.8 % 89 28.3 % -11.63%

Managers

Managers TitleAgeSince
Chief Executive Officer 53 Nov. 09
Chief Tech/Sci/R&D Officer 51 21-06-20
Human Resources Officer - 22-01-31
Corporate Officer/Principal 54 Oct. 31
General Counsel 56 21-07-11

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 22-03-21
Director/Board Member 60 23-03-31
Director/Board Member 65 14-08-05
Director/Board Member 57 22-03-21
Chairman 63 21-05-23
Director/Board Member 62 22-03-21
Chief Executive Officer 53 Nov. 09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 23,326,783 23,112,511 ( 99.08 %) 0 99.08 %

Shareholders

NameEquities%Valuation
Camber Capital Management LP
8.581 %
2,000,000 8.581 % 13 M $
BlackRock Advisors LLC
8.429 %
1,964,550 8.429 % 13 M $
Brown Capital Management LLC
6.695 %
1,560,409 6.695 % 10 M $
Vanguard Fiduciary Trust Co.
5.827 %
1,358,072 5.827 % 9 M $
Morgan Stanley Investment Management, Inc.
4.449 %
1,036,990 4.449 % 7 M $
Ameriprise Financial Services LLC
4.117 %
959,559 4.117 % 6 M $
Weatherbie Capital LLC
3.394 %
790,971 3.394 % 5 M $
Bridgeway Capital Management LLC
2.627 %
612,300 2.627 % 4 M $
Meros Investment Management L.P.
2.530 %
589,630 2.530 % 4 M $
Renaissance Technologies LLC
2.372 %
552,800 2.372 % 4 M $

Company contact information

Inogen, Inc.

859 Ward Drive

93111, Goleta

+805 562 0500

http://www.inogen.com
address Inogen, Inc.(INGN)